I. Karaiskos

发表

Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016.

M. Souli, I. Galani, H. Giamarellou, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae

H. Giamarellou, I. Karaiskos, L. Galani, 2013, Antimicrobial Agents and Chemotherapy.

ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study (Preprint)

Varun S. Sharma, K. Kaye, Phillip J. Bergen, 2020 .

Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae

Brian T. Tsuji, Su Mon Aye, J. Li, 2020, Antimicrobial Agents and Chemotherapy.

Carbapenem-Sparing Strategies for ESBL Producers: When and How

H. Giamarellou, I. Karaiskos, 2020, Antibiotics.

Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens

M. Souli, I. Galani, H. Giamarellou, 2019, Expert opinion on drug metabolism & toxicology.

Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae

A. Oliver, R. Bonomo, Y. Carmeli, 2018, Infection Control & Hospital Epidemiology.

Large vessel vasculitis in a patient with acute Q-fever: A case report

G. Kitas, H. Giamarellou, I. Karaiskos, 2014, IDCases.

Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies

I. Galani, H. Giamarellou, I. Karaiskos, 2021, Expert review of anti-infective therapy.

Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study

S. Levidiotou, E. Maltezos, M. Lazanas, 2017, PloS one.

Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.

Su Mon Aye, J. Li, T. Velkov, 2019, The Journal of infection.

Evolution of epidemiological characteristics of infective endocarditis in Greece.

E. Maltezos, T. Tsaganos, S. Miyakis, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

M. Souli, I. Galani, H. Giamarellou, 2019, BMC Infectious Diseases.

Application of a Loading Dose of Colistin Methanesulphonate (CMS) in Critically Ill

A. Armaganidis, D. Plachouras, A. Antoniadou, 2012 .

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches

H. Giamarellou, I. Karaiskos, 2014, Expert opinion on pharmacotherapy.

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria (cid:1)

O. Cars, A. Armaganidis, D. Plachouras, 2009 .

Oral fosfomycin for the treatment of chronic bacterial prostatitis

V. Sakka, I. Karaiskos, L. Galani, 2019, The Journal of antimicrobial chemotherapy.

In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece.

E. Petinaki, A. Antoniadou, M. Souli, 2020, The Journal of antimicrobial chemotherapy.

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients

H. Giamarellou, I. Karaiskos, 2022, Antibiotics.

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

A. Antoniadou, M. Souli, I. Galani, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

A. Antoniadou, M. Souli, I. Galani, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing K.pneumoniae isolates.

I. Galani, H. Giamarellou, I. Karaiskos, 2020, Journal of global antimicrobial resistance.

Combination therapy for extensively-drug resistant gram-negative bacteria

A. Antoniadou, H. Giamarellou, I. Karaiskos, 2017, Expert review of anti-infective therapy.

Plazomicin: an investigational therapy for the treatment of urinary tract infections

M. Souli, H. Giamarellou, I. Karaiskos, 2015, Expert opinion on investigational drugs.

Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review.

H. Giamarellou, I. Karaiskos, L. Galani, 2013, International journal of antimicrobial agents.

Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series.

A. Andreou, H. Giamarellou, I. Karaiskos, 2013, International journal of antimicrobial agents.

Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019

A. Antoniadou, M. Souli, I. Galani, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis

M. Bassetti, A. Cortegiani, L. Scudeller, 2021, Journal of fungi.

Population Pharmacokinetics of Fosfomycin in Critically Ill Patients

D. Koulenti, G. Dimopoulos, S. Parker, 2015, Antimicrobial Agents and Chemotherapy.

Nosocomial dissemination of Providencia stuartii isolates producing extended-spectrum β-lactamases VEB-1 and SHV-5, metallo-β-lactamase VIM-1, and RNA methylase RmtB.

M. Souli, I. Galani, H. Giamarellou, 2013, Journal of global antimicrobial resistance.

Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.

Christos G Gogos, K. Arvaniti, G. Daikos, 2020, The Journal of antimicrobial chemotherapy.

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How

G. Poulakou, I. Karaiskos, V. Rapti, 2019, Front. Public Health.

Management of KPC-producing Klebsiella pneumoniae infections.

M. Bassetti, E. Righi, C. Viscoli, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Colistin: still a lifesaver for the 21st century?

M. Souli, I. Galani, H. Giamarellou, 2017, Expert opinion on drug metabolism & toxicology.

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

A. Armaganidis, O. Cars, A. Armaganidis, 2009, Antimicrobial Agents and Chemotherapy.

Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration

O. Cars, A. Armaganidis, D. Plachouras, 2012, Antimicrobial Agents and Chemotherapy.

Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

Lena E. Friberg, Apostolos Armaganidis, Konstantinos Pontikis, 2012, Antimicrobial Agents and Chemotherapy.

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.

A. Oliver, E. Pérez-Nadales, R. Bonomo, 2017, The Lancet. Infectious diseases.

Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients

A. Koutsoukou, K. Ioannidis, H. Giamarellou, 2015, Antimicrobial Agents and Chemotherapy.

How do we optimize the prescribing of intravenous polymyxins to increase their longevity and efficacy in critically ill patients?

M. Bassetti, D. Giacobbe, I. Karaiskos, 2021, Expert opinion on pharmacotherapy.

Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.

G. Dimopoulos, E. Roilides, H. Giamarellou, 2014, International journal of antimicrobial agents.

Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.

K. Ioannidis, H. Giamarellou, L. Friberg, 2016, International journal of antimicrobial agents.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

A. Farcomeni, A. Oliver, R. Bonomo, 2018, International journal of antimicrobial agents.

Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae

M. Souli, H. Giamarellou, I. Karaiskos, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock.

S. Zakynthinos, G. Nakos, A. Armaganidis, 2020, The Journal of antimicrobial chemotherapy.

Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades

M. Bassetti, V. di Pilato, G. Rossolini, 2023, Annals of medicine.

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

A. Antoniadou, M. Souli, I. Galani, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae

Minh Duc Cao, L. Coin, M. Cooper, 2017, bioRxiv.

Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant MDR Klebsiella pneumoniae clinical isolates from the same patients before and after colistin treatment.

Su Mon Aye, J. Li, T. Velkov, 2020, The Journal of antimicrobial chemotherapy.

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort

A. Oliver, R. Bonomo, Y. Carmeli, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012–2013

V. Baka, M. Souli, H. Giamarellou, 2016, Infectious diseases.

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae.

A. Oliver, R. Bonomo, Y. Carmeli, 2016, Mayo Clinic proceedings.

Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.

A. Antoniadou, M. Souli, I. Galani, 2019, Clinical Microbiology and Infection.

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

B. Souweine, A. Nica, P. Póvoa, 2023, Intensive Care Medicine.

Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis.

M. Meisner, A. Armaganidis, G. Dimopoulos, 2011, Journal of critical care.

Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria

D. Giacobbe, I. Karaiskos, 2020, Antibiotics.

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review

K. Akinosoglou, I. Karaiskos, Z. Athanassa, 2023, Microorganisms.

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

A. Antoniadou, M. Souli, I. Galani, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey

E. P. Dellinger, P. Barie, M. Tovani-Palone, 2022, World Journal of Emergency Surgery.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

A. Farcomeni, R. Bonomo, Y. Carmeli, 2018, International journal of antimicrobial agents.

Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis.

M. Bassetti, E. Righi, F. Taccone, 2020, The Journal of infection.

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches

H. Giamarellou, I. Karaiskos, 2014, Expert opinion on pharmacotherapy.

Antimicrobial Stewardship in the Hospital Setting: A Narrative Review

I. Karaiskos, Lamprini Galani, H. Giamarellou, 2023, Antibiotics.

In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study

A. Ferke, A. Antoniadou, I. Galani, 2023, European Journal of Clinical Microbiology & Infectious Diseases.

In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece

M. Souli, I. Galani, I. Karaiskos, 2024, The Journal of antimicrobial chemotherapy.

High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections.

H. Giamarellou, I. Karaiskos, S. Kokkoris, 2015, International journal of antimicrobial agents.